A. Cor, et al. 2011. Electrogene therapy with interleukin‐12 in canine mast cell tumors. Radiol Oncol 45:31–39.
534 Pena, F.J., J.A. Gines, J. Duque, et al. 2006. Endometrial adenocarcinoma and mucometra in a 6‐year‐old Alaska Malamute dog. Reprod Domest Anim 41:189–190.
535 Petersen, M.E. and D.V. Becker. 1995. Radioiodine treatment of 524 cats with hyperthyroidism. J Am Vet Med Assoc 207:1422–1428.
536 Peterson, M.E., P.P. Kintzer, J.R. Hurley, et al. 1989. Radioactive iodine treatment of a functional thyroid carcinoma producing hyperthyroidism in a dog. J Vet Intern Med 3:20–25.
537 Peterson, M.E., P.P. Kintzer, and A.I. Hurvitz. 1988. Methimazole treatment of 262 cats with hyperthyroidism. J Vet Intern Med 2:150–157.
538 Phelps, H.A., C.A. Kuntz, R.J. Milner, et al. 2011. Radical excision with five‐centimeter margins for treatment of feline injection‐site sarcomas: 91 cases (1998–2002). J Am Vet Med Assoc 239:97–106.
539 Phillips, B., B.E. Powers, W.S. Dernell, et al. M. 2009. Use of single‐agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. J Am Anim Hosp Assoc 45:33–38.
540 Pirkey‐Ehrhart, N., S.J. Withrow, R.C. Straw, et al. 1995. Primary rib tumors in 54 dogs. J Am Anim Hosp Assoc 31:65–69.
541 Pisarev, M.A., M.A. Dagrosa, L. Thomasz, et al. 2006. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma]. Medicina (B Aires) 66:569–573.
542 Poirier, V.J., W.M. Adams, L.J. Forrest, et al. 2006. Radiation therapy for incompletely excised grade II canine mast cell tumors. J Am Anim Hosp Assoc 42:430–434.
543 Poirier, V.J., K.E. Burgess, W.M. Adams, et al. 2004a. Toxicity, dosage, and efficacy of vinorelbine (Navelbine) in dogs with spontaneous neoplasia. J Vet Intern Med 18:536–539.
544 Poirier, V.J., L.J. Forrest, W.M. Adams, et al. 2004b. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: A pilot study. J Am Anim Hosp Assoc 40:131–136.
545 Poirier, V.J., D.H. Thamm, I.D. Kurzman, et al. 2002. Liposome‐encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine‐associated sarcoma in cats. J Vet Intern Med 16:726–731.
546 Polton, G.A. and M.J. Brearley. 2007. Clinical stage, therapy, and prognosis in canine anal sac gland carcinoma. J Vet Intern Med 21:274–280.
547 Polton, G.A., M.J. Brearley, S.M. Powell, et al. 2008. Impact of primary tumour stage on survival in dogs with solitary lung tumours. J Small Anim Pract 49:66–71.
548 Polton, G.A., R.N. White, M.J. Brearley, et al. 2007. Improved survival in a retrospective cohort of 28 dogs with insulinoma. J Small Anim Pract 48:151–156.
549 Pooya, H.A., B. Seguin, D.R. Mason, et al. 2004. Biomechanical comparison of cortical radial graft versus ulnar transposition graft limb‐sparing techniques for the distal radial site in dogs. Vet Surg 33:301–308.
550 Popovitch, C.A., M.J. Weinstein, and M.H. Goldschmidt. 1994. Chondrosarcoma: A retrospective study of 97 dogs (1987–1990). J Am Anim Hosp Assoc 30:81–85.
551 Porcellato, I., L. Menchetti, C. Brachelente, et al. 2017. Feline injection‐site sarcoma. Vet Pathol 54:204–211.
552 Post, G.S. and G.N. Mauldin. 1992. Radiation and adjuvant chemotherapy for the treatment of thyroid adenocarcinoma in dogs. In Proceedings Veterinary Cancer Society, 12th Annual Conference, Pacific Grove, CA, Oct 18–21, pp. 43–44 (abstr).
553 Postorino, N.C., R.J. Berg, B.E. Powers, et al. 1988. Prognostic variables for canine haemangiopericytoma: 50 cases (1979–1984). J Am Anim Hosp Assoc 24:501–509.
554 Postorino, N.C., S.J. Susaneck, S. J. Withrow, et al. 1989. Single agent therapy with Adriamycin for canine lymphosarcoma. J Am Anim Hosp Assoc 25:221–225.
555 Potanas, C.P., S. Padgett, and R.M. Gamblin. 2015. Surgical excision of anal sac apocrine gland adenocarcinomas with and without adjunctive chemotherapy in dogs: 42 cases (2005–2011). J Am Vet Med Assoc 246:877–884.
556 Pratschke, K.M., M.J. Atherton, J.A. Sillito, et al. 2013. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008–2012). J Am Vet Med Assoc 243:1436–1441.
557 Proulx, D.R., D.M. Ruslander, R.K. Dodge, et al. 2003. A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation. Vet Radiol Ultrasound 44:352–359.
558 Prpich, C.Y., A.C. Santamaria, J.O. Simcock, et al. 2014. Second intention healing after wide local excision of soft tissue sarcomas in the distal aspects of the limbs in dogs: 31 cases (2005–2012). J Am Vet Med Assoc 244:187–194.
559 Prymak, C., L.J. McKee, M.H. Goldschmidt, et al. 1988. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J Am Vet Med Assoc 193:706–712.
560 Quintin‐Colonna, F., P. Devauchelle, D. Fradelizi, et al. 1996. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin‐2. Gene Ther 3:1104–1112.
561 Ramirez, O., III, R.K. Dodge, R.L. Page, et al. 1999. Palliative radiotherapy of appendicular osteosarcoma in 95 dogs. Vet Radiol Ultrasound 40:517–522.
562 Ramirez, G.A., J. Altimira, and M. Vilafranca. 2015. Cartilaginous tumors of the larynx and trachea in the dog: Literature review and 10 additional cases (1995–2014). Vet Pathol 52:1019–1026.
563 Ramos‐Vara, J.A., M.E. Beissenherz, M.A. Miller, et al. 2000. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Vet Pathol 37:597–608.
564 Rassnick, K.M., D.B. Bailey, E.K. Malone, et al. 2014. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma. J Am Anim Hosp Assoc 50:167–173.
565 Rassnick, K.M., C.E. Goldkamp, H.N. Erb, et al. 2006. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993–2003). J Am Vet Med Assoc 229:401–406.
566 Rassnick, K.M., G.E. Mauldin, R. Al‐Sarraf, et al. 2002. Mopp chemotherapy for treatment of resistant lymphoma in dogs: A retrospective study of 117 cases (1989–2000). J Vet Intern Med 16:576–580.
567 Rassnick, K.M., M.C. McEntee, H.N. Erb, et al. 2007. Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma. J Vet Intern Med 21:1364–1373.
568 Rassnick, K.M., A.S. Moore, D.S. Russell, et al. 2010. Phase II, open‐label trial of single‐agent CCNU in dogs with previously untreated histiocytic sarcoma. J Vet Intern Med 24:1528–1531.
569 Rassnick, K.M., A.S. Moore, L.E. Williams, et al. 1999. Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 13:601–605.
570 Rassnick, K.M., D.M. Ruslander, S.M. Cotter, et al. 2001. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989–2000). J Am Vet Med Assoc 218:1444–1448.
571 Rebhun, R.B., M.S. Kent, S.A. Borrofka, et al. 2011. Chop chemotherapy for the treatment of canine multicentric T‐cell lymphoma. Vet Comp Oncol 9:38–44.
572 Renwick, A. and E. Scurrell. 2013. Orthogonal bone plate stabilization for limb‐sparing surgery. Vet Comp Orthop Traumatol 26:505–509.
573 Huppes, R.R., L.Z. Crivellenti, A. Barboza De Nardi, et al. 2017. Radical cystectomy and cutaneous ureterostomy in 4 dogs with trigonal transitional cell carcinoma: Description of technique and case series. Vet Surg 46:111–119.
574 Riccardo, F., S. Iussich, L. Maniscalco, et al. 2014. CSPG4‐specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA. Clin Cancer Res 20:3753–3762.
575 Ridgway, T.D. and M.D. Lucroy. 2003. Phototoxic effects of 635‐nm light on canine transitional cell carcinoma cells incubated